BR0109770A - Uso de galantamina para o tratamento do comportamento neuropsiquiátrico associado com a doença de alzheimer - Google Patents

Uso de galantamina para o tratamento do comportamento neuropsiquiátrico associado com a doença de alzheimer

Info

Publication number: BR0109770A
Authority: BR; Brazil
Prior art keywords: alzheimer; galantamine; disease; behavior associated; treat neuropsychiatric
Prior art date: 2000-04-03

Application number

BR0109770-9A

Other languages

English (en)

Portuguese (pt)

Inventor

Win Louis Julien Parys

Michael Pontecorvo

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-03

Filing date

2001-03-28

Publication date

2003-02-04

2001-03-28 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-02-04 Publication of BR0109770A publication Critical patent/BR0109770A/pt

Links

ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title abstract 9
229960003980 galantamine Drugs 0.000 title abstract 5
208000024827 Alzheimer disease Diseases 0.000 title abstract 4
ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title abstract 4
208000017667 Chronic Disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000087 stabilizing effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Plant Substances (AREA)

BR0109770-9A 2000-04-03 2001-03-28 Uso de galantamina para o tratamento do comportamento neuropsiquiátrico associado com a doença de alzheimer BR0109770A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19425900P	2000-04-03	2000-04-03
PCT/EP2001/003553 WO2001074339A2 (fr)	2000-04-03	2001-03-28	Utilisation de la galantamine dans le traitement du comportement neuropsychiatrique associe a la maladie d'alzheimer

Publications (1)

Publication Number	Publication Date
BR0109770A true BR0109770A (pt)	2003-02-04

Family

ID=22716898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR0109770-9A BR0109770A (pt)	2000-04-03	2001-03-28	Uso de galantamina para o tratamento do comportamento neuropsiquiátrico associado com a doença de alzheimer

Country Status (20)

Country	Link
EP (1)	EP1272192A2 (fr)
JP (1)	JP2003528913A (fr)
KR (1)	KR20020086911A (fr)
CN (1)	CN1430514A (fr)
AU (2)	AU2001265844B2 (fr)
BG (1)	BG107093A (fr)
BR (1)	BR0109770A (fr)
CA (1)	CA2310926C (fr)
CZ (1)	CZ20023543A3 (fr)
EE (1)	EE200200554A (fr)
HR (1)	HRP20020778A2 (fr)
HU (1)	HUP0300566A3 (fr)
IL (1)	IL152061A0 (fr)
MX (1)	MXPA02009777A (fr)
NO (1)	NO20024746L (fr)
PL (1)	PL361272A1 (fr)
RU (1)	RU2002129298A (fr)
SK (1)	SK15422002A3 (fr)
WO (1)	WO2001074339A2 (fr)
ZA (1)	ZA200207935B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6617361B2 (en) *	1999-11-05	2003-09-09	Be Able, Llc	Behavior chemotherapy
ES2293287T3 (es)	2003-07-25	2008-03-16	F. Hoffmann-La Roche Ag	Combinacion de antagonista de mglur2 y de inhibidor de ache para el tratamiento de trastornos neurologicos agudos y/o cronicos.
DE10338544B4 (de) *	2003-08-19	2017-08-31	Janssen Pharmaceutica N.V.	Buccale Formulierungen des Galanthamins und deren Anwendungen
AU2009229372C1 (en)	2008-03-27	2017-02-02	Chase Pharmaceuticals Corporation	Use and composition for treating dementia
WO2013160728A1 (fr)	2012-04-26	2013-10-31	Alma Mater Studiorum - Universita' Di Bologna	Composés à double ciblage pour le traitement de la maladie d'alzheimer
BG66818B1 (bg) *	2013-03-07	2019-01-31	Berbee Beheer B. V.	Състав на екстракт от hippeastrum papilio за производство на лекарствени средства и хранителни добавки
AU2016264228B2 (en) *	2015-05-18	2019-06-13	Synaptec Development Llc	Galantamine clearance of amyloidß
WO2023036105A1 (fr) *	2021-09-09	2023-03-16	上海日馨医药科技股份有限公司	Méthode de traitement d'une maladie neurodégénérative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4663318A (en) *	1986-01-15	1987-05-05	Bonnie Davis	Method of treating Alzheimer's disease
DE19509663A1 (de) *	1995-03-17	1996-09-19	Lohmann Therapie Syst Lts	Verfahren zur Isolierung von Galanthamin
GB9600080D0 (en) *	1996-01-04	1996-03-06	Chiroscience Ltd	Resolution process
AU1738800A (en)	1998-11-23	2000-06-13	Bonnie Davis	Dosage formulations for acetylcholinesterase inhibitors
AU775914B2 (en) *	1998-12-24	2004-08-19	Janssen Pharmaceutica N.V.	Controlled release galantamine composition
CA2310950C (fr) *	2000-04-03	2005-11-08	Janssen Pharmaceutica N.V.	Posologie de galantamine efficace qui reduit les effets secondaires
CA2310990A1 (fr) *	2000-04-03	2000-10-09	Michael Pontecorvo	Utilisation de la galantamine pour le traitement de la maladie d'alzheimer; ciblage de la cause sous-jacente de la maladie

2000
- 2000-06-27 CA CA002310926A patent/CA2310926C/fr not_active Expired - Lifetime
2001
- 2001-03-28 EP EP01943200A patent/EP1272192A2/fr not_active Withdrawn
- 2001-03-28 RU RU2002129298/14A patent/RU2002129298A/ru not_active Application Discontinuation
- 2001-03-28 PL PL36127201A patent/PL361272A1/xx not_active Application Discontinuation
- 2001-03-28 KR KR1020027011063A patent/KR20020086911A/ko not_active Ceased
- 2001-03-28 SK SK1542-2002A patent/SK15422002A3/sk unknown
- 2001-03-28 AU AU2001265844A patent/AU2001265844B2/en not_active Ceased
- 2001-03-28 BR BR0109770-9A patent/BR0109770A/pt not_active IP Right Cessation
- 2001-03-28 HR HR20020778A patent/HRP20020778A2/xx not_active Application Discontinuation
- 2001-03-28 HU HU0300566A patent/HUP0300566A3/hu unknown
- 2001-03-28 CN CN01807334A patent/CN1430514A/zh active Pending
- 2001-03-28 WO PCT/EP2001/003553 patent/WO2001074339A2/fr not_active Ceased
- 2001-03-28 CZ CZ20023543A patent/CZ20023543A3/cs unknown
- 2001-03-28 EE EEP200200554A patent/EE200200554A/xx unknown
- 2001-03-28 IL IL15206101A patent/IL152061A0/xx unknown
- 2001-03-28 MX MXPA02009777A patent/MXPA02009777A/es unknown
- 2001-03-28 AU AU6584401A patent/AU6584401A/xx active Pending
- 2001-03-28 JP JP2001572084A patent/JP2003528913A/ja not_active Withdrawn
2002
- 2002-09-12 BG BG107093A patent/BG107093A/bg unknown
- 2002-10-02 NO NO20024746A patent/NO20024746L/no not_active Application Discontinuation
- 2002-10-02 ZA ZA200207935A patent/ZA200207935B/en unknown

Also Published As

Publication number	Publication date
RU2002129298A (ru)	2004-03-27
KR20020086911A (ko)	2002-11-20
HUP0300566A2 (hu)	2003-06-28
BG107093A (bg)	2003-06-30
PL361272A1 (en)	2004-10-04
AU6584401A (en)	2001-10-15
WO2001074339A3 (fr)	2002-09-12
HUP0300566A3 (en)	2004-10-28
WO2001074339A2 (fr)	2001-10-11
NO20024746D0 (no)	2002-10-02
NO20024746L (no)	2002-11-28
CA2310926A1 (fr)	2000-10-04
AU2001265844B2 (en)	2005-04-14
SK15422002A3 (sk)	2003-04-01
CZ20023543A3 (cs)	2003-03-12
ZA200207935B (en)	2004-01-30
EE200200554A (et)	2004-04-15
MXPA02009777A (es)	2003-03-27
HRP20020778A2 (en)	2004-04-30
EP1272192A2 (fr)	2003-01-08
IL152061A0 (en)	2003-05-29
CN1430514A (zh)	2003-07-16
JP2003528913A (ja)	2003-09-30
CA2310926C (fr)	2002-10-15

Similar Documents

Publication	Publication Date	Title
BR0012136A (pt)	2002-06-11	Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR9807673A (pt)	2000-02-15	Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica.
BR0115109A (pt)	2005-10-18	Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
DK0713701T3 (da)	2000-04-03	2-Brommelatonin til behandling af søvnforstyrrelser
BR0008926A (pt)	2001-12-18	Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
BR0013122A (pt)	2002-04-30	Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
WO2002002518A3 (fr)	2002-08-08	Composes pour traiter la maladie d'alzheimer
BR0114913A (pt)	2003-07-01	Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BR0111913A (pt)	2004-01-06	Análogos de gabapentina para distúrbios do sono
KR970704429A (ko)	1997-09-06	심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases)
BR0114392A (pt)	2003-09-02	Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv
BR0312845A (pt)	2005-06-07	Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas
BR9509006A (pt)	1998-06-23	Composiçao para aplicaçao tópica na pele composiçao farmacêutica uso de um inibidor de síntese de colesterol e processo para o tratamento mitigaçao ou prevençao de distúrbios de pele
EP0401903A3 (fr)	1992-04-29	Utilisation de vanilloides dans le traitement des maladies ou des troubles respiratoires
BR0109770A (pt)	2003-02-04	Uso de galantamina para o tratamento do comportamento neuropsiquiátrico associado com a doença de alzheimer
BR0107628A (pt)	2002-10-08	l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
KR890011589A (ko)	1989-08-21	벤즈아미드의 용도
BR0208405A (pt)	2004-03-30	Compostos de diidropirimina substituìdos com ciano e seu uso para tratar doenças
BR9812660A (pt)	2000-08-22	Composições e métodos para tratar distúrbios respiratórios
BR0112547A (pt)	2003-07-01	Processo para encontrar compostos que sejam adequados para o tratamento e/ou profilaxia de obesidade
BR9813549A (pt)	2000-10-10	Processo para prevenção e tratamento de miocárdio afetado por lesão
BR0107960A (pt)	2002-10-29	Tratamento de condições alérgicas e inflamatórias
BR9908885A (pt)	2000-11-21	Medicamento para a profilaxia e/ou tratamento de mastocarcinoma, compreendendo um inibidor esteróide de aromatase
DE3875349D1 (de)	1992-11-19	Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
NO990450L (no)	1999-01-29	Behandling av sinnslidelser

Legal Events

Date	Code	Title	Description
2009-08-25	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE 8A. ANUIDADES.
2010-04-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009